No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
21 – 100
Sex
Any
Study type
Observational
Participants needed
60 (estimated)
Sponsor
National University Hospital, Singapore · Other
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Primary Objective To examine the tolerability of Mepitel Film in the prevention of RD patients undergoing whole breast or chest wall RT in the hot and humid weather in Singapore
Secondary Objectives To evaluate the incidence of acute radiation dermatitis, quality of life, satisfaction, and cost analysis of Mepitel Film use.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 21 years old (legal age of maturity in Singapore)
* Male or female
* Informed consent
* Patients have undergone a mastectomy with or without reconstruction or breast-conserving surgery.
* Histological confirmation of breast carcinoma (invasive or in situ carcinoma)
* Pat…
Inclusion Criteria:
* Age ≥ 21 years old (legal age of maturity in Singapore)
* Male or female
* Informed consent
* Patients have undergone a mastectomy with or without reconstruction or breast-conserving surgery.
* Histological confirmation of breast carcinoma (invasive or in situ carcinoma)
* Patients are scheduled to receive hypofractionated (40Gy in 15 daily fractions or 26Gy in 5 daily fractions) photon-based RT
* Patient treated with or without tissue the addition of equivalent bolus and/or boost.
* Can communicate in English or be aided by a translator.
Exclusion Criteria:
* Prior RT to any portion of the planned treatment site.
* Patients will receive partial breast external beam RT, proton beam therapy, or brachytherapy.
* Patients with active rash, pre-existing dermatitis, or other conditions within the treatment area may make skin assessment for the study difficult per treating physician discretion.
* Known history of adhesive, tape or silicon allergy or sensitivity.
* Concomitant cytotoxic chemotherapy
* Bilateral breast pathology requiring concurrent bilateral breast or chest wall RT.
* Current inflammatory breast cancer or gross dermal involvement at initiation of RT.
* Patient has a Karnofsky Performance Status score \<60.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.